Leaderboard
Anzeige
Fr
|
De
Feedback
|
Impressum
|
Sitemap
Aucun choix d'articles!
Panier
Vous êtes ici:
Recherche de documentation spécialisée
»
Pancréas
»
Néoplasie
16. Novembre 2026
Recherche
Gastroplattform
Néoplasie
Recherche avancée
Dépistage / diagnostic
Traitements
Directives
Perfectionnement
Nouvelles
Recherche de documentation spécialisée
Voies biliaires
Foie
Estomac / intestins
Œsophage
Pancréas
Néoplasie
Pancréatite
Autres
Congrès et sessions
Services et outils
Liens
Rect Top
Anzeige
Écriture:
Page 1 de 3110
Articles 1 - 20 / 62199
Letter to the Editor: Evaluation of P-POSSUM Risk Scoring System in Prediction of Morbidity and Mortality after Pancreaticoduodenectomy.
Chirurgia (Bucur)
Y.
PMID: 43037109 [PubMed - indexed for MEDLINE]
High-Sensitivity Detection of Early Pancreatic Cancer Using a Structured Scoring System Among Clinically Selected Outpatients: A Nationwide Prospective Study.
United European Gastroenterol J
Sagami R, Yamao K, Shimizu A, Nishikiori H, Yoshida K, Yoshida A, Takenaka M, Imai H, Sekine K, Murakami M, Fujimori N, Nagayama R, Ueki T, Nakahodo J, Okamoto K, Kinoshita M, Takayama Y, Amano Y, Mizukami K, Murakami K, Hanada K.
PMID: 43036074 [PubMed - indexed for MEDLINE]
Unifying functional experimental systems with clinical predictive technologies for personalized care in PDAC.
Mol Cancer
López-Gil JC, Campa D, Rizzato C, Espinet E, Barreto E, Sainz B Jr, Earl J.
PMID: 43035764 [PubMed - indexed for MEDLINE]
Epitranscriptomic RNA modifications in cancer DNA damage response: mechanistic links between RNA fate, genome maintenance, and therapy resistance.
J Transl Med
Yang X, Wang H, He J, Yang S, Zhao M, Zhao L, Wang J, Chen X, Xu X, Qin H.
PMID: 43035716 [PubMed - indexed for MEDLINE]
Bioabsorbable spacer-assisted high-dose proton beam therapy for unresectable locally advanced pancreatic cancer of the body or tail: a feasibility and safety study.
Radiother Oncol
Nakamura H, Nanno Y, Terashima K, Matsuo Y, Takahashi D, Niwa Y, Demizu Y, Tokumaru S, Okimoto T, Sasaki R, Komatsu S.
PMID: 43035152 [PubMed - as supplied by publisher]
Phase I dose-escalation study of stereotactic body radiotherapy with elective nodal irradiation for borderline resectable and unresectable locally advanced pancreatic cancer.
Radiother Oncol
Umezawa R, Mizuma M, Nakagawa K, Katsuta Y, Tanaka S, Yamamoto T, Takahashi N, Suzuki Y, Kishida K, Omata S, Harada H, Kadoya N, Unno M, Jingu K.
PMID: 43035150 [PubMed - as supplied by publisher]
Tumo​r-associated macrophages in ovarian, prostate, thyroid and pancreatic neuroendocrine tumors: molecular crosstalk and therapeutic perspectives.
Mol Biol Rep
Patel D, Ravindran S, Sojan MM, Suresh PS.
PMID: 43034947 [PubMed - indexed for MEDLINE]
Clinicopathological and prognostic features of pancreatic acinar cell carcinoma: a nationwide multicenter study in Japan.
J Gastroenterol
Kanno A, Fukushima N, Sata N, Notohara K, Hayashi M, Furukawa T, Higuchi R, Okuwaki K, Ohtsuka M, Watanabe T, Shioji K, Abe T, Kitagawa H, Muraki R, Hashimoto D, Satake T, Yamaguchi J, Takahara N, Nakahodo J, Yasuda H, Okazaki K, Takeyama Y, Yamaue H, Satoi S, Masamune A, Japan Pancreas Society Clinical Research Promotion Committee Group (Corporate Authorship).
PMID: 43033256 [PubMed - as supplied by publisher]
Periodontitis and pancreatic cancer: the oral-gut microbial axis, pathogenic mechanisms, and potential therapeutic implications.
J Oral Microbiol
Fan L, Hong G, Sun J, Zhou Y, Shi J.
PMID: 43032645 [PubMed]
Explainable artificial intelligence identifies circulating microRNA candidate biomarkers for liquid biopsy-based pancreatic cancer detection.
Front Artif Intell
Mandal S, Ansari MA, Chanu WP.
PMID: 43032186 [PubMed]
Ozone therapy in colorectal cancer.
Front Oncol
Li Y, Pu R, Yang S, Chen H, Zhang X.
PMID: 43032072 [PubMed]
Complement in cancer-associated fibroblasts: sources, regulation and context dependence.
Front Immunol
Lei K.
PMID: 43032046 [PubMed - indexed for MEDLINE]
Periostin within the tumor microenvironment: molecular insights and immunomodulatory roles in cancer.
Front Immunol
Zhao Y, Yu Y, Li S, Xu L, Chen W, Lv J.
PMID: 43032026 [PubMed - indexed for MEDLINE]
Food Environment, Food Access, and Disparities in Pancreatic Cancer Outcomes: A Narrative Review of Evidence Gaps and Future Directions.
Nutrients
Liu C, Burch C, Bandy V, Gibson A, Vudatha V, Freudenberger D, Lambdin J, Herremans K, Riner A, Fernandez L, Trevino J.
PMID: 43030263 [PubMed - indexed for MEDLINE]
DNA Repair Pathways as Determinants of PARP Inhibitor Resistance and Therapeutic Targets in Cancer.
Int J Mol Sci
Lavudi K, Renjith MS, Pithana Sai Venkata Vijay C, Kokkanti RR, Pandey P, Ponneganti S.
PMID: 43028061 [PubMed - indexed for MEDLINE]
Changing Course: Semaphorins and Plexins as Novel Therapeutic Opportunities and Key Regulators of Pancreatic Cancer Microenvironment.
Int J Mol Sci
Bertalmio N, Marino FAL, Brundu S, Rustichelli S, Giraudo E.
PMID: 43028035 [PubMed - indexed for MEDLINE]
Cancer Risk Linked to Ultra-Processed Foods: Epidemiological Findings, Potential Mechanisms, and Research Outlook.
Foods
Zhao M, Zhang X.
PMID: 43027519 [PubMed]
The Cholecystokinin-B Receptor as a Candidate Diagnostic Biomarker and Translational Target for Precision Oncology in Pancreatic Cancer.
Cancers (Basel)
Smith JP.
PMID: 43026872 [PubMed]
Trends and Patterns in Gastrointestinal Cancer Burden in Asia, 1990-2023: Evidence from the Global Burden of Disease Study 2023.
Cancers (Basel)
Guo L, Zhu C, Yuan J, Cai L, Luan H, Chen H, Zheng Y, Liu Y.
PMID: 43026856 [PubMed]
Treatment Strategies and Future Directions for Locally Advanced Pancreatic Cancer.
Cancers (Basel)
Turner KM, Gurewitz JB, Frakes JM, Denbo JW, Malafa MP, Hodul PJ, Kim DW, Sinnamon AJ.
PMID: 43026841 [PubMed]
Articles 1 - 20 / 62199
Page 1 de 3110
Rect Bottom
Anzeige
Adserver Footer
Intervalle de temps demandé
--sans limitation--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy
|
Publicité